Stacey Musto
Nurse Practitioner · Neptune, NJNPI 1023522349
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 315 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 22.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,228 and has fallen 79.8% since, to $450 in 2025. Among nurse practitioner clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 315 payments — averaging $24.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$2K
- E.r. Squibb & Sons, L.L.C.$1K
- AstraZeneca$757
- Esperion Therapeutics, Inc.$645
- Amgen$480
- Novartis$298
- plus $3K from 32 others
What the payments were for
- Food & beverage$7,60699%
- Education$681%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 45 | $1,691 |
| E.r. Squibb & Sons, L.L.C. | 49 | $1,016 |
| AstraZeneca | 15 | $757 |
| Esperion Therapeutics, Inc. | 23 | $645 |
| Amgen | 31 | $480 |
| Novartis | 21 | $298 |
| Abiomed | 4 | $249 |
| Novo Nordisk | 15 | $221 |
| Kestra Medical Technology Services, Inc. | 2 | $209 |
| Irhythm Technologies, Inc. | 6 | $158 |
| Medtronic | 1 | $146 |
| Merck | 9 | $138 |
| Abbott | 6 | $132 |
| Sanofi-aventis U.S. LLC | 8 | $129 |
| Johnson & Johnson | 8 | $124 |
| Atricure, Inc. | 3 | $111 |
| W. L. Gore & Associates, Inc. | 8 | $108 |
| Amarin Pharma, Inc. | 7 | $104 |
| Boston Scientific | 5 | $102 |
| Cvrx, Inc. | 6 | $95 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $86 |
| Kowa Pharmaceuticals America, Inc. | 6 | $84 |
| Scpharmaceuticals Inc. | 4 | $84 |
| Philips North America LLC | 3 | $83 |
| Cardiovascular Systems Inc. | 6 | $73 |
| Biotronik Inc. | 3 | $52 |
| Tactile Systems Technology Inc | 2 | $44 |
| Angiodynamics, Inc. | 2 | $42 |
| Pfizer | 2 | $36 |
| Lexicon Pharmaceuticals, Inc. | 2 | $32 |
| Astellas Pharma US Inc | 2 | $29 |
| Amryt Pharma Holdings Ltd | 1 | $20 |
| Edwards Lifesciences | 1 | $19 |
| Bard Peripheral Vascular, Inc. | 1 | $18 |
| Lundbeck LLC | 1 | $18 |
| Impulse Dynamics (USA) Inc. | 1 | $17 |
| Daiichi Sankyo Inc. | 1 | $13 |
| Vivaquant Inc, Dba Rhythm Express | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- JARDIANCE$1,209
- FARXIGA$586
- NEXLIZET$363
- NEXLETOL$363
- CAMZYOS$235
- Assure WCD$191
- Impella$151
- Reveal LINQ$146
- ELIQUIS$122
How this compares
$7,674 in reported general payments places this provider in the 95th percentile of 2,138 nurse practitioner providers in New Jersey.
Other nurse practitioner in Neptune
- Walter ElliottNeptune$13K
- Joni PrenticeNeptune$7K
- Nancy BonnetMorristown$407K
- Vanessa CoppolaCloster$205K
- Olufunmilayo IloriUnion$133K
- Janice BeitzHaddon Heights$75K
- Adewale AdefowojuUnion$70K
- Sophia KimEnglewood$70K
- Elizabeth FletcherCamden$62K
- Lannae EwingLinwood$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.